2nd Circuit Court of Appeals revives lawsuits linking prenatal Tylenol use to autism and ADHD
Photo: Washington Examiner
Health Added 60d ago 5 outlets

2nd Circuit Court of Appeals revives lawsuits linking prenatal Tylenol use to autism and ADHD

The 2nd U.S. Circuit Court of Appeals unanimously revived hundreds of lawsuits alleging that prenatal acetaminophen exposure caused autism spectrum disorder or ADHD in children. The panel ruled that U.S. District Judge Denise Cote erred in excluding expert testimony from three scientists, including Harvard's public health dean. The cases are returned to Cote for further proceedings, though the court stressed it was not deciding whether acetaminophen actually causes these conditions.

18
Divergence score
5 outlets covered it, splitting into 5 framing camps across 3 bias groups.
5 camps
3 bias groups
Market signalBETA
The spectrum · how 5 outlets placed this story
LeftCenterRight
Washington Examiner
Globe and Mail
Financial Times
The Hill
Reuters
Horizontal = outlet biasColor = this story's framing
Supportive of action
Neutral
Dismissive
Critical
Alarmist
International angle
Widest split · the two outlets furthest apart, and who published first
Furthest apart on this story
Washington Examiner
Appeals court revives lawsuit against Tylenol brought by parents of children with autism
Political and scientific context foregrounded · negative
The Hill
Appeals court revives lawsuits claiming link between acetaminophen, ADHD and autism
Legal evidentiary standard highlighted · neutral
How Washington Examiner and The Hill compare across every story →
First to report
  1. Reutersfirst
  2. Financial Times+9.5 h
  3. Globe and Mail+10.9 h
  4. The Hill+14.9 h
  5. Washington Examiner+31.4 h
By each outlet's earliest publish time in this story. Feeds that index slowly can appear later than they printed.
The split, in one line
Coverage largely agrees on the legal ruling but splits on emphasis: the Washington Examiner foregrounds the political dimension via Trump and RFK Jr., while the Globe and Mail leads with market impact on Kenvue and the Kimberly-Clark acquisition, and other outlets focus narrowly on the legal and evidentiary standard.
How each outlet covered it

Only the right is covering this

One side of the spectrum has stayed silent. That absence is itself a signal.

0
LEFT OUTLETS
0 of 5 outlets covering this story sit on that side of the spectrum.
0LEFT OUTLETS
THE RIGHT2 outlets · mostly critical
Appeals court revives lawsuit against Tylenol brought by parents of children with autism
WE Washington Examiner RIGHT
DOWN THE MIDDLE

“U.S. appeals court revives more than 500 lawsuits against Tylenol-maker Kenvue over autism claims” · Globe and Mail, The Hill, Reuters

+Hide the full sourcingSee how all 5 outlets put it
6 tracked claims across 5 outlets
Fact ledger
All6Claimed1Corroborated5
1/5
Claimed
Kenvue shares fell 1.8% and Kimberly-Clark shares fell 2.7% following the ruling, and Kenvue has agreed to be acquired by Kimberly-Clark for over $40 billion
Corroborated
Disputed